MentionFox
Home › funding signals › Nocion Therapeutics, Inc.
Company · SEC filings

Nocion Therapeutics, Inc. funding history

Nocion Therapeutics, Inc. has 2 Form D filings on record, from 2024-03-13 to 2026-03-13. Together its new offerings report $54.11M sold.

Pitching, partnering or investing alongside them? See who really runs and owns Nocion Therapeutics, Inc.

Free to see. No signup.

Is this your company?

Funding historyFounders and team

Is this your company?

Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

Nocion Therapeutics, Inc.: Raised $23M, Form D filed 2026-03-13
Share on LinkedIn Share on X Download image

Is Nocion Therapeutics, Inc. a real, registered company?

Nocion Therapeutics, Inc. is a registered filer with the SEC (CIK 1841279) and has filed since 2024-03-13. 2 filings are on record, the latest on 2026-03-13.

A filing shows the company exists and what it reports about itself. It is not an audit or a rating.

Who runs Nocion Therapeutics, Inc.?

Nocion Therapeutics, Inc.'s filings name Freddie Dear, James Ellis, Julie Grant and 8 more as its officers, directors or promoters.

How much has Nocion Therapeutics, Inc. raised?

Its new offerings report $54.11M sold across 2 offerings, as its own filings state.

Run the free check on Nocion Therapeutics, Inc. →

Based
WATERTOWN, MASSACHUSETTS
Industry group
Pharmaceuticals
Filings
2
Raised (new offerings)
$54.11M

Every filing

FiledTypeAmount soldTotal offeringRecords
2026-03-13New offering
first sale 2025-12-15
$23M$23Mdetails · SEC filing
2024-03-13New offering
first sale 2024-02-29
$31.11M$70.04MSEC filing

Keep reading

More on Nocion Therapeutics, Inc. and the records around it.

The people at Nocion Therapeutics, Inc.

Nocion Therapeutics, Inc. elsewhere on the record

What do you want to do with Nocion Therapeutics, Inc.?

Want the whole picture on Nocion Therapeutics, Inc.?

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on Nocion Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Nocion Therapeutics, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    2 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

How the total is counted: the amount sold on each new offering, added together. Amendments are left out, because an amendment restates an offering already counted. A filing whose figures have not been read yet shows a dash and adds nothing.

Every figure here is read from Nocion Therapeutics, Inc.'s own filings with the SEC. The people those filings name are on the team page.

Filings & events

Fundraising filings

Follow this companyRSS

Tools for this story

Each opens in a new tab, filled in for Nocion Therapeutics, Inc.. With no account yet, you sign up free and land on the result.

Cite this page

Permanent URL: https://mentionfox.com/company/nocion-therapeutics-inc
Last updated 2026-11-01
Primary record: SEC filing 1 · SEC filing 2
How much has Nocion Therapeutics, Inc. raised? $54.11M in 2 SEC filings. MentionFox, 2026-11-01. https://mentionfox.com/company/nocion-therapeutics-inc